Login to Your Account



Slow Development Road for Immunotherapies

Overall Survival: Not Just 'Gold Standard' but Only Option

By Brian Orelli


Monday, March 28, 2011
No Abstract

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription